Lonza and Oxford Nanopore collaborate to advance mRNA Therapeutics
To improve mRNA product analysis, the Lonza Group Ltd. and Oxford Nanopore Technologies plc. are working together to develop and market a test to assess multiple critical quality attributes of mRNA products